Roche has already shown an interest in exosome technology this year, in July signing a potential billion-dollar deal with US biotech PureTech Health. The project is focused on using a milk-derived ...

The high mortality rate is primarily driven by delayed diagnosis, rapid metastasis, and frequent recurrence. Tumor-derived exosomes (TEXs) have emerged as critical mediators in NSCLC progression, ...

Feb. 4, 2025 — Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in ... Feb. 4, 2025 — Researchers have ...

Welcome to the Cosmetics and Medical Device Division of BiCT. We are a team that believes in the positive impact of Evolution in harmony with Nature, to create a better future every day.